Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis

Cardiovascular and Interventional Radiology, 05/29/2012

DEB–DOX results, with high rates of 5–year survival for patients, not amenable to curative treatments. Number of lesions, lesion vascularity, and local response were significant independent determinants of 5–year survival.

Print Article Summary Cat 2 CME Report